Evaluating provider knowledge, perception, and concerns about cannabinoid use in pediatric dermatology

Nidhi Shah; Anna Yasmine Kirkorian; Adam J Friedman

doi:10.1111/pde.14539

Evaluating provider knowledge, perception, and concerns about cannabinoid use in pediatric dermatology

Pediatr Dermatol. 2021 May;38(3):694-696. doi: 10.1111/pde.14539. Epub 2021 Mar 18.

Authors

Nidhi Shah¹, Anna Yasmine Kirkorian^{1

2}, Adam J Friedman¹

Affiliations

¹ The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
² Division of Dermatology, Children's National Hospital, Washington, DC, USA.

PMID: 33738826
DOI: 10.1111/pde.14539

Abstract

As the use of medical cannabinoids expands, the value and acceptance in pediatric dermatology is poorly characterized. To better assess the current climate, this survey evaluated pediatric dermatologists' familiarity and knowledge about medical cannabis and their interest to research and use cannabinoids. While the fund of knowledge and acceptance was high, providers voiced concerns about psychoactive effects of cannabis and substance abuse among their pediatric patients.

Keywords: CBD; cannabinoid; dermatology; marijuana; medical cannabis; pediatric dermatology.

MeSH terms

Cannabinoids* / adverse effects
Cannabis*
Child
Dermatology*
Humans
Perception
Surveys and Questionnaires

Substances

Cannabinoids